The Tasmanian Atrial Fibrillation Study (TAFS): Differences in Stroke Prevention According to Sex

Gender Differences in Antithrombotic Treatment for Newly Diagnosed Atrial Fibrillation: The GLORIA-AF Registry Program

(2018) Michał Mazurek et al.   AMERICAN JOURNAL OF MEDICINE

Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation

(2018) Peter Brønnum Nielsen et al.   CIRCULATION

Stroke Risk Stratification: CHA2DS2-VA or CHA2DS2-VASc?

(2018) Thure Filskov Overvad et al.   Heart Lung and Circulation

National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Diagnosis and Management of Atrial Fibrillation 2018

(2018) David Brieger et al.   Heart Lung and Circulation

Revisiting sex differences in outcomes in non-valvular atrial fibrillation: a population-based cohort study

(2017) Christel Renoux et al.   EUROPEAN HEART JOURNAL

Sex Differences in the Use of Oral Anticoagulants for Atrial Fibrillation: A Report From the National Cardiovascular Data Registry (NCDR ® ) PINNACLE Registry

(2017) Lauren E. Thompson et al.   Journal of the American Heart Association

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

(2016) Paulus Kirchhof et al.   EUROPEAN HEART JOURNAL

Validation of Risk Scoring System Excluding Female Sex From CHA2DS2-VASc in Japanese Patients With Nonvalvular Atrial Fibrillation　– Subanalysis of the J-RHYTHM Registry –

(2015) Hirofumi Tomita et al.   CIRCULATION JOURNAL

Does Sex Affect Anticoagulant Use for Stroke Prevention in Nonvalvular Atrial Fibrillation?: The Prospective Global Anticoagulant Registry in the FIELD-Atrial Fibrillation

(2015) G. Y. H. Lip et al.  

Gender differences in stroke prevention in atrial fibrillation in general practice: using the GRASP-AF audit tool

(2015) E. Shantsila et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Does Sex Affect Anticoagulant Use for Stroke Prevention in Nonvalvular Atrial Fibrillation?: The Prospective Global Anticoagulant Registry in the FIELD-Atrial Fibrillation

(2015) G. Y. H. Lip et al.   Circulation-Cardiovascular Quality and Outcomes

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

(2014) Craig T. January et al.   CIRCULATION

Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Observational Research Programme Pilot survey on Atrial Fibrillation

(2014) Gregory Y.H. Lip et al.   EUROPACE

Is female sex a risk factor for stroke and thromboembolism in patients with atrial fibrillation? A systematic review and meta-analysis

(2014) A. J. Wagstaff et al.   QJM-AN INTERNATIONAL JOURNAL OF MEDICINE

Antithrombotic Therapy for Atrial Fibrillation

(2012) John J. You et al.   CHEST

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

(2012) et al.   EUROPACE

The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0–1: A nationwide cohort study

(2012) Christian Torp-Pedersen et al.   THROMBOSIS AND HAEMOSTASIS

Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

(2010) et al.   EUROPEAN HEART JOURNAL